Banks Intensively Supplement Capital, Large Banks Prefer Issuing Bonds, Small Banks Focus on Private Placement 银行业密集补充资本，大行热衷发债小行主打定增

Weihai Bank's private placement of 150 million shares to Hengyuan Holdings, with all proceeds to replenish core tier-1 capital—was a swift, decisive move, like a patient in urgent need of a blood transfusion seizing a blood bag. But this bag of blood, I'm afraid, may only last until the next health checkup. The banking sector's collective "capital replenishment" campaign appears to be a proactive measure, yet beneath the surface lies an anxious struggle for "book-based life support."

The persistent narrowing of net interest margins is like a blunt knife hanging overhead, slicing away profits bit by bit, leaving banks increasingly anemic in their endogenous capital generation. As a result, exogenous "blood transfusions" have become a lifeline. Look at the scene: large banks wield influence in the bond market, issuing secondary perpetual bonds as densely as raindrops—these are the "privileged passes" from capital markets. Meanwhile, smaller and medium-sized banks can only scramble around, desperately seeking directional share issuances and pleading with shareholders to "infuse capital." "Large banks issue bonds, small banks go for private placements"—this isn't just divergence; it's naked solidification of class under differing resource endowments. Major banks attract institutional takers effortlessly, even while lying down, whereas smaller banks may have to rely on shareholder goodwill for private placements, often with strings attached.

What's more ironic is that this "capital replenishment spree" is unfolding against a backdrop of seemingly stable banking sector earnings reports. Profit figures still appear on the books, yet the red line of capital adequacy ratios has already become a source of restless anxiety. What does this reveal? It shows that the "quality" and "thickness" of profits can no longer buffer against potential future bad loans and regulatory demands. The so-called "replenishment" is not for expansion but for defense—to appear less vulnerable in an impending storm. This is essentially the same as a company frantically raising funds not for growth but to pay interest on old debts.

Weihai Bank's 1.5 billion-share private placement is but a small ripple in the broader wave of capital replenishment across the banking industry. However, it precisely mirrors the collective predicament of current small and medium-sized banks: severe business homogenization, squeezed profit margins, and weak bargaining power in capital markets. Equity expansion feels more like a stopgap measure, trading equity dilution for temporary breathing room. What do new shareholders see in this? The future value of a banking license? Or the potential "shell" resources? Business logic is sometimes more complex than it appears.

If this "capital replenishment" campaign merely remains at the level of number games and regulatory compliance—without addressing the fundamental transformation of banks' own business models, such as completely breaking the reliance on interest margins and truly building risk management and service capabilities that endure across cycles—then every bit of capital added today is merely accumulating greater energy for tomorrow's risks. Capital is ammunition, but strategy is the scope and the timing of the shot. Right now, many banks seem frantically focused on stockpiling ammunition, possibly without yet determining whether future battles will be fought in urban guerrilla warfare or in the vast expanse of naval and aerial combat.

威海银行向恒源控股定增1.5亿股，募资全额补血核心一级资本——动作干脆利落，像个急需输血的病人抓到了血袋。但这袋血，恐怕只够撑过下一次体检。银行业的集体“补血”运动，表面是未雨绸缪，内里却透着一股“账面续命”的焦灼。

净息差持续收窄是那把悬在头顶的钝刀子，一刀刀割掉利润，让银行内源性造血能力日渐贫血。于是，外源性“输血”就成了救命稻草。看看那架势：大行们在债券市场上呼风唤雨，二永债发行密如雨点，那是资本市场的“特权通行证”；而中小银行呢？只能四处奔走，求爹爹告奶奶地搞定向增发，拉几个股东来“输血”。“大行发债、小行定增”，这格局哪是分化，分明是资源禀赋下赤裸裸的阶层固化。大行躺着发行都有机构抢，小行定增可能得看股东脸色，甚至附带一堆条件。

更讽刺的是，这股补充资本的“热潮”，是在银行业绩报告看似还算稳健的背景下涌动的。报表上还有利润，可资本充足率那根红线，已经逼得大家坐立难安。这说明什么？说明利润的“质量”和“厚度”已经撑不起未来可能的坏账和监管要求了。所谓的“补充”，不是为了扩张，而是为了防御，为了在可能到来的风暴中，让自己显得不那么脆弱。这和一家公司疯狂融资不是为了增长，而是为了先付清旧债的利息，本质上是同一回事。

威海银行这1.5亿股定增，放在整个银行业资本补充的浪潮里，只是一朵小浪花。但它精准地映射了当前中小银行的集体困境：业务同质化严重，利润空间被压缩，在资本市场上缺乏议价权。增资扩股更像是权宜之计，是用股权稀释换取短暂的生存空间。新股东进来，图的是什么？是未来牌照的价值，还是某个潜在的“壳”资源？商业逻辑有时比表面复杂。

这场“补血”运动若只是停留在数字游戏和监管达标的层面，而不触及银行自身商业模式的根本转型——比如彻底摆脱对息差的依赖，真正构建穿越周期的风控与服务能力——那么今天补充的每一分资本，都不过是在为明天的风险积蓄更大的能量。资本是弹药，但战略才是瞄准镜和开火的时机。现在看来，很多银行在拼命往弹药库塞东西，却可能还没想清楚，未来要面对的，究竟是巷战，还是海空战。